Market-Moving News for September 12th
Portfolio Pulse from ryanfaloona@benzinga.com
Ascent Solar Technologies (ASTI) has achieved a new benchmark of 15.5% in cell production efficiency of its CIGS solar technology. Lyra Therapeutics' (LYRA) BEACON Phase 2 study of LYR-220 for chronic rhinosinusitis in patients with prior ethmoid sinus surgery met its primary endpoint. GoDaddy (GDDY) shares are trading higher after Starboard Value sent a letter to the company, stating it believes GoDaddy is deeply undervalued with significant opportunities for shareholder value creation.
September 12, 2023 | 12:35 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ascent Solar Technologies has achieved a new benchmark in cell production efficiency, which could potentially increase its market competitiveness.
The increase in cell production efficiency could lead to higher product quality and lower costs, potentially increasing ASTI's market share and profitability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
GoDaddy shares are trading higher after Starboard Value stated it believes the company is undervalued, indicating potential for increased shareholder value.
Starboard Value's letter could lead to increased investor interest in GDDY, potentially driving up the stock price. The assertion that the company is undervalued suggests there may be significant upside potential.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Lyra Therapeutics' BEACON Phase 2 study of LYR-220 for chronic rhinosinusitis met its primary endpoint, indicating potential success for the drug.
Meeting the primary endpoint in a Phase 2 study is a significant milestone, indicating that the drug is effective. This could lead to increased investor confidence and a rise in LYRA's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100